KRT8 |
KRT8, CYK8: Keratin, type II cytoskeletal 8 |
LMNB1 |
LMNB1, LMN2, LMNB: Lamin-B1 |
4.12 |
Evidence |
|
F3 |
F3: Tissue factor precursor |
CBLB |
CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B |
4.12 |
Evidence |
|
CGA |
CGA: Glycoprotein hormones alpha chain precursor |
ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
4.12 |
Evidence |
|
CD22 |
CD22, SIGLEC2: B-cell receptor CD22 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
4.12 |
Evidence |
|
ANXA2 |
ANXA2, ANX2, ANX2L4, CAL1H, LPC2D: Annexin A2 |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
4.12 |
Evidence |
|
IL2RB |
IL2RB: Interleukin-2 receptor subunit beta precursor |
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
4.12 |
Evidence |
|
CGA |
CGA: Glycoprotein hormones alpha chain precursor |
MAP2K6 |
MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki |
4.12 |
Evidence |
|
KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
NUP50 |
NUP50, NPAP60L, PRO1146: Nucleoporin 50 kDa |
4.107 |
Evidence |
O
|
UBE2D2 |
UBE2D2, UBC4, UBCH5B: Ubiquitin-conjugating enzyme E2 D2 |
RNF25 |
RNF25: E3 ubiquitin-protein ligase RNF25 |
4.107 |
Evidence |
|
NBN |
NBN, NBS, NBS1, P95: Nibrin |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
4.107 |
Evidence |
|
KRT18 |
KRT18: Uncharacterized protein KRT18 |
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
4.107 |
Evidence |
|
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
RHOA |
RHOA, ARH12, ARHA, RHO12: Transforming protein RhoA precursor |
4.107 |
Evidence |
|
SOS1 |
SOS1: Son of sevenless homolog 1 |
FRS2 |
FRS2: Fibroblast growth factor receptor substrate 2 |
4.107 |
Evidence |
O
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
GRIN2B |
GRIN2B, NMDAR2B: Glutamate [NMDA] receptor subunit epsilon-2 precursor |
4.102 |
Evidence |
|
F9 |
F9: Coagulation factor IX precursor |
ARHGAP12 |
ARHGAP12: Rho GTPase-activating protein 12 |
4.102 |
Evidence |
|
PDGFA |
PDGFA, PDGF1: Platelet-derived growth factor A chain precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
4.1 |
Evidence |
|
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
CXADR |
CXADR, CAR: Coxsackievirus and adenovirus receptor precursor |
4.092 |
Evidence |
|
TAF5 |
TAF5, TAF2D: Transcription initiation factor TFIID subunit 5 |
TAF13 |
TAF13, TAF2K, TAFII18: Transcription initiation factor TFIID subunit 13 |
4.09 |
Evidence |
|
PES1 |
PES1: Pescadillo homolog 1 |
HIST1H2AC |
HIST1H2AC, H2AFL: Histone H2A type 1-C |
4.09 |
Evidence |
|
RFC1 |
IPI00375359 |
HIST1H2AC |
HIST1H2AC, H2AFL: Histone H2A type 1-C |
4.09 |
Evidence |
|
H2AFZ |
H2AFZ, H2AZ: Histone H2A.Z |
HIST1H2AC |
HIST1H2AC, H2AFL: Histone H2A type 1-C |
4.09 |
Evidence |
|
PSMB2 |
PSMB2: Proteasome subunit beta type-2 |
CDK3 |
CDK3: Cell division protein kinase 3 |
4.09 |
Evidence |
|
TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
HIST1H4A |
HIST1H4A, H4/A, HIST1H4B, H4/I, H4/G, HIST1H4D, H4/B, H4/J, HIST1H4F, HIST4H4, H |
4.09 |
Evidence |
|
TAF6 |
TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 |
HIST1H2AC |
HIST1H2AC, H2AFL: Histone H2A type 1-C |
4.09 |
Evidence |
|
WASL |
WASL: Neural Wiskott-Aldrich syndrome protein |
ACTG1 |
ACTR2, ARP2: Actin-related protein 2 |
4.09 |
Evidence |
|